HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew D Troyer Selected Research

Matthew D Troyer Research Topics

Disease

5Sleep Initiation and Maintenance Disorders (Insomnia)
09/2016 - 03/2015
4Parkinson Disease (Parkinson's Disease)
01/2022 - 07/2004
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 11/2016
2Mucopolysaccharidosis II (Hunter Syndrome)
01/2022 - 07/2020
2Schizophrenia (Dementia Praecox)
01/2018 - 03/2013
1Disease Progression
07/2020
1Mental Disorders (Mental Disorder)
01/2018
1Bipolar Disorder (Manic Depressive Psychosis)
01/2018
1Hallucinations (Hallucination)
08/2016
1Apnea
01/2016
1Obstructive Sleep Apnea
01/2016
1Sleepiness
11/2015
1Chronic Obstructive Pulmonary Disease (COPD)
03/2015
1Hypoxia (Hypoxemia)
03/2015
1Type 2 Diabetes Mellitus (MODY)
11/2014
1Psychotic Disorders (Schizoaffective Disorder)
03/2013

Drug/Important Bio-Agent (IBA)

6suvorexantIBA
09/2016 - 03/2015
5Orexin Receptor AntagonistsIBA
09/2016 - 03/2015
4Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2006
3EnzymesIBA
01/2022 - 01/2019
3Peptides (Polypeptides)IBA
01/2019 - 11/2016
3Amyloid (Amyloid Fibrils)IBA
01/2019 - 11/2016
3alpha-SynucleinIBA
11/2006 - 07/2004
2Pharmaceutical PreparationsIBA
07/2020 - 08/2016
2verubecestatIBA
01/2019 - 11/2016
2Hypnotics and Sedatives (Sedatives)IBA
08/2016 - 03/2015
1Phosphotransferases (Kinase)IBA
01/2022
1Iduronic Acid (Iduronate)IBA
01/2022
1Leucine (L-Leucine)FDA Link
01/2022
1GlycosaminoglycansIBA
07/2020
1Biomarkers (Surrogate Marker)IBA
07/2020
1asenapineFDA Link
01/2018
1Zolpidem (Ambien)FDA LinkGeneric
08/2016
1Hallucinogens (Psychedelics)IBA
08/2016
1GoldIBA
03/2015
1Glucagon Receptors (Glucagon Receptor)IBA
11/2014
1Olanzapine (Zyprexa)FDA Link
03/2013
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
03/2013
1Dopamine (Intropin)FDA LinkGeneric
09/2006

Therapy/Procedure

1Therapeutics
07/2020